Literature DB >> 12634383

Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines.

Jason S Knight1, Ke Lan, Chitra Subramanian, Erle S Robertson.   

Abstract

Epstein-Barr virus (EBV) nuclear antigen 3C (EBNA3C) is a known regulatory transcription factor that has been shown to interact with histone deacetylase 1 (HDAC1) when cotransfected in human cell lines and by in vitro binding experiments. Previous studies have shown that EBNA3C interacts with p300 and prothymosin alpha (ProTalpha) in EBV-infected cells and may be involved in recruiting acetyltransferases to the chromatin for acetylation of histones and transcriptional activation. EBNA3C has also been shown to function as a repressor of transcription when directed to promoters. In this report, we show that EBNA3C complexed with ProTalpha can also recruit deacetylase activity and associates in a complex that includes HDAC1 and HDAC2 in human B cells. A complex of EBNA3C and ProTalpha coimmunoprecipitated with HDAC1 and HDAC2 in cell lines stably expressing EBNA3C. Additionally, this complex associated with the mSin3A and NCoR corepressors in EBNA3C-expressing cell lines and may function in a complex with additional transcription factors known to be repressors of transcription. EBNA3C in complex with ProTalpha recruited deacetylase activity in cell lines stably expressing EBNA3C, and this activity was shown to be partially sensitive to trichostatin A (TSA). This suggests an association with other deacetylases that are insensitive to the general inhibitory effects of TSA, as the entire activity was not abolished in multiple assays. The association between EBNA3C and the corepressors as well as HDACs is likely to depend on the presence of ProTalpha in the complex. Immunoprecipitation with anti-ProTalpha antibody immunoprecipitated EBNA3C and the other repressors, whereas immunoprecipitation with anti-EBNA3C antibody resulted in little or no association with these molecules associated with transcription repression. Clearly, EBNA3C functions as a component of a number of dynamic complexes which function in repression and activation of transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634383      PMCID: PMC150657          DOI: 10.1128/jvi.77.7.4261-4272.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Chromatin unfolding and activation by HMGN(*) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-07       Impact factor: 13.807

2.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay.

Authors:  C Díaz-Jullien; A Pérez-Estévez; G Covelo; M Freire
Journal:  Biochim Biophys Acta       Date:  1996-09-05

4.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

Authors:  L Young; C Alfieri; K Hennessy; H Evans; C O'Hara; K C Anderson; J Ritz; R S Shapiro; A Rickinson; E Kieff
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

5.  Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis.

Authors:  C Subramanian; M A Cotter; E S Robertson
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

6.  Geographical and tribal distribution of the African lymphoma in Uganda.

Authors:  D Burkitt; D Wright
Journal:  Br Med J       Date:  1966-03-05

7.  Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.

Authors:  B Zhao; C E Sample
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Epstein-Barr virus replication in oropharyngeal epithelial cells.

Authors:  J W Sixbey; J G Nedrud; N Raab-Traub; R A Hanes; J S Pagano
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

9.  Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.

Authors:  S Fennewald; V van Santen; E Kieff
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

10.  Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin.

Authors:  A Adams; G Bjursell; C Kaschka-Dierich; T Lindahl
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

View more
  68 in total

1.  Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

Authors:  Michelle J West; Helen M Webb; Alison J Sinclair; Derek N Woolfson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 2.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

3.  Novel function of prothymosin alpha as a potent inhibitor of human immunodeficiency virus type 1 gene expression in primary macrophages.

Authors:  Arevik Mosoian; Avelino Teixeira; Anthony A High; Robert E Christian; Donald F Hunt; Jeffrey Shabanowitz; Xinyan Liu; Mary Klotman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.

Authors:  Ke Lan; Daniel A Kuppers; Erle S Robertson
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.

Authors:  Charles M Chau; Paul M Lieberman
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.

Authors:  Adrienne Chen; Bo Zhao; Elliott Kieff; Jon C Aster; Fred Wang
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.

Authors:  Seiji Maruo; Yi Wu; Taku Ito; Teru Kanda; Elliott D Kieff; Kenzo Takada
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 8.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

9.  During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomes.

Authors:  Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1.

Authors:  Sungwook Lee; Shuhei Sakakibara; Seiji Maruo; Bo Zhao; Michael A Calderwood; Amy M Holthaus; Chiou-Yan Lai; Kenzo Takada; Elliott Kieff; Eric Johannsen
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.